Physician profile
William P Stanell
NPI 1164496279
$2,934.95
in general payments reported to CMS, 2019-2025
13 companies · $1,800 in 2025
The $1,800 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $281 · 2023: $53.52 · 2024: $800 · 2025: $1,800.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,600 · Food and Beverage: $53.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,600.00 |
| Food and Beverage | $53.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $2,600.00 | 2024-2025 | Bovine Collagen |
| Allergan, INC. | $42.39 | 2019 | |
| Abbvie INC. | $37.37 | 2019 | |
| Pfizer INC. | $30.49 | 2019-2023 | |
| Vertical Pharmaceuticals, LLC | $29.62 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.10 | 2019 | |
| Merck Sharp & Dohme LLC | $29.09 | 2019 | |
| Therapeuticsmd, INC. | $28.64 | 2019 | |
| Avion Pharmaceuticals | $25.62 | 2019 | |
| Exeltis, USA INC. | $23.46 | 2019 | |
| Millicent US INC | $22.86 | 2019 | |
| Hologic Sales and Service, LLC | $19.50 | 2023 | Aptima |
| Sumitomo Pharma America, INC. | $16.81 | 2023 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Stanell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.